chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash macular
Clinical narrative: cold sensation on my legs; shivers, feeling cold; rash inside my legs, not itchy more like hives or prickly heat, tiny little red dots extended at the top of my knee; rash inside my legs, not itchy more like hives or prickly heat, tiny little red dots extended at the top of my knee; rash inside my legs, not itchy more like hives or prickly heat, tiny little red dots extended at the top of my knee; fast heart beat 1st hour after vaccine; headache; This spontaneous case was reported by a consumer and describes the occurrence of MILIARIA (rash inside my legs, not itchy more like hives or prickly heat, tiny little red dots extended at the top of my knee), RASH MACULAR (rash inside my legs, not itchy more like hives or prickly heat, tiny little red dots extended at the top of my knee), HEART RATE INCREASED (fast heart beat 1st hour after vaccine), LIMB DISCOMFORT (cold sensation on my legs) and CHILLS (shivers, feeling cold) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced HEART RATE INCREASED (fast heart beat 1st hour after vaccine) and HEADACHE (headache). On 05-Feb-2021, the patient experienced MILIARIA (rash inside my legs, not itchy more like hives or prickly heat, tiny little red dots extended at the top of my knee), RASH MACULAR (rash inside my legs, not itchy more like hives or prickly heat, tiny little red dots extended at the top of my knee), CHILLS (shivers, feeling cold) and RASH (rash inside my legs, not itchy more like hives or prickly heat, tiny little red dots extended at the top of my knee). On an unknown date, the patient experienced LIMB DISCOMFORT (cold sensation on my legs). At the time of the report, MILIARIA (rash inside my legs, not itchy more like hives or prickly heat, tiny little red dots extended at the top of my knee), RASH MACULAR (rash inside my legs, not itchy more like hives or prickly heat, tiny little red dots extended at the top of my knee), HEART RATE INCREASED (fast heart beat 1st hour after vaccine), LIMB DISCOMFORT (cold sensation on my legs), CHILLS (shivers, feeling cold), RASH (rash inside my legs, not itchy more like hives or prickly heat, tiny little red dots extended at the top of my knee) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication were not provided No treatment medications were not provided   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Followup received on 07-MAY-2021 and contains e-mail details.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Dyschromatopsia, Erythema, Pain in extremity, Pruritus
Clinical narrative: Red became itchy; Saw colors like a Kaleidoscope and fell; Redness; Sore arm at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of DYSCHROMATOPSIA (Saw colors like a Kaleidoscope and fell), PRURITUS (Red became itchy), ERYTHEMA (Redness) and PAIN IN EXTREMITY (Sore arm at the injection site) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE and CITALOPRAM HYDROBROMIDE (CELEXA [CITALOPRAM HYDROBROMIDE]) for an unknown indication.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced ERYTHEMA (Redness) and PAIN IN EXTREMITY (Sore arm at the injection site). On 20-Jan-2021, the patient experienced DYSCHROMATOPSIA (Saw colors like a Kaleidoscope and fell). On 22-Jan-2021, the patient experienced PRURITUS (Red became itchy). On 22-Jan-2021, PAIN IN EXTREMITY (Sore arm at the injection site) had resolved. On 29-Jan-2021, DYSCHROMATOPSIA (Saw colors like a Kaleidoscope and fell) had resolved. At the time of the report, PRURITUS (Red became itchy) outcome was unknown and ERYTHEMA (Redness) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included Poison ivy cream on the itch.   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: NNI
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Myalgia, Pyrexia
Clinical narrative: fever 103F; body ache; coughing; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of PYREXIA (fever 103F), MYALGIA (body ache) and COUGH (coughing) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 from March 2020 to April 2020. Concomitant products included DIPHENHYDRAMINE for Allergy, ACETYLSALICYLIC ACID (BABY ASPIRIN) for Antiplatelet therapy, ATORVASTATIN for Cholesterol, NIFEDIPINE and LOSARTAN for Hypertension.    On 06-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced PYREXIA (fever 103F), MYALGIA (body ache) and COUGH (coughing). The patient was treated with PARACETAMOL on 07-Feb-2021 at an unspecified dose and frequency. At the time of the report, PYREXIA (fever 103F), MYALGIA (body ache) and COUGH (coughing) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Pain in extremity
Clinical narrative: Body ache; Headache; Chills; Sore arm; This spontaneous case was reported by a nurse and describes the occurrence of PAIN IN EXTREMITY (Sore arm), PAIN (Body ache), HEADACHE (Headache) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 20-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 20-Jan-2021, the patient experienced PAIN (Body ache), HEADACHE (Headache) and CHILLS (Chills). At the time of the report, PAIN IN EXTREMITY (Sore arm), PAIN (Body ache), HEADACHE (Headache) and CHILLS (Chills) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Gait inability, Livedo reticularis, Myopathy, Rash, Skin discolouration
Clinical narrative: Purple discoloration of the lower right leg; Loss of  muscle control of legs; She could not walk for approximately 1 month; Rash under right thigh; Reporting a reaction to my COVID 19 injection; Mottling underneath the skin; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Reporting a reaction to my COVID 19 injection), LIVEDO RETICULARIS (Mottling underneath the skin), SKIN DISCOLOURATION (Purple discoloration of the lower right leg), MYOPATHY (Loss of  muscle control of legs) and GAIT INABILITY (She could not walk for approximately 1 month) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Surgery (Spinal surgery and had been undergoing physical therapy.) since 30-Jun-2020.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (Reporting a reaction to my COVID 19 injection), LIVEDO RETICULARIS (Mottling underneath the skin), SKIN DISCOLOURATION (Purple discoloration of the lower right leg), MYOPATHY (Loss of  muscle control of legs), GAIT INABILITY (She could not walk for approximately 1 month) and RASH (Rash under right thigh). At the time of the report, VACCINATION SITE REACTION (Reporting a reaction to my COVID 19 injection), LIVEDO RETICULARIS (Mottling underneath the skin), SKIN DISCOLOURATION (Purple discoloration of the lower right leg), MYOPATHY (Loss of  muscle control of legs), GAIT INABILITY (She could not walk for approximately 1 month) and RASH (Rash under right thigh) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication and treatment provided   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Significant follow-up received on 27-MAY-2021: Added patient demographic details, medical history and events.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site reaction
Clinical narrative: Purple discoloration of the lower right leg; Loss of  muscle control of legs; She could not walk for approximately 1 month; Rash under right thigh; Reporting a reaction to my COVID 19 injection; Mottling underneath the skin; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Reporting a reaction to my COVID 19 injection), LIVEDO RETICULARIS (Mottling underneath the skin), SKIN DISCOLOURATION (Purple discoloration of the lower right leg), MYOPATHY (Loss of  muscle control of legs) and GAIT INABILITY (She could not walk for approximately 1 month) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Surgery (Spinal surgery and had been undergoing physical therapy.) since 30-Jun-2020.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (Reporting a reaction to my COVID 19 injection), LIVEDO RETICULARIS (Mottling underneath the skin), SKIN DISCOLOURATION (Purple discoloration of the lower right leg), MYOPATHY (Loss of  muscle control of legs), GAIT INABILITY (She could not walk for approximately 1 month) and RASH (Rash under right thigh). At the time of the report, VACCINATION SITE REACTION (Reporting a reaction to my COVID 19 injection), LIVEDO RETICULARIS (Mottling underneath the skin), SKIN DISCOLOURATION (Purple discoloration of the lower right leg), MYOPATHY (Loss of  muscle control of legs), GAIT INABILITY (She could not walk for approximately 1 month) and RASH (Rash under right thigh) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication and treatment provided   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Significant follow-up received on 27-MAY-2021: Added patient demographic details, medical history and events.
Age: 87.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Ear discomfort, Head discomfort, Influenza like illness, Myalgia, Somnolence
Clinical narrative: Drowsiness; Heavy head; Ear stuffed up; Flu like symptoms; Whole body aches mostly when laying down in bed; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Drowsiness), HEAD DISCOMFORT (Heavy head), EAR DISCOMFORT (Ear stuffed up), INFLUENZA LIKE ILLNESS (Flu like symptoms) and MYALGIA (Whole body aches mostly when laying down in bed) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.    Co-suspect product included non-company product PARACETAMOL (TYLENOL) for an unknown indication.    The patient's past medical history included COVID-19 in February 2020.   On 06-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started PARACETAMOL (TYLENOL) (unknown route) at an unspecified dose. On 21-Feb-2021, the patient experienced SOMNOLENCE (Drowsiness), HEAD DISCOMFORT (Heavy head), EAR DISCOMFORT (Ear stuffed up), INFLUENZA LIKE ILLNESS (Flu like symptoms) and MYALGIA (Whole body aches mostly when laying down in bed). The patient was treated with NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. At the time of the report, SOMNOLENCE (Drowsiness), HEAD DISCOMFORT (Heavy head), EAR DISCOMFORT (Ear stuffed up) and INFLUENZA LIKE ILLNESS (Flu like symptoms) outcome was unknown and MYALGIA (Whole body aches mostly when laying down in bed) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. patient still had whole body aches when she laying on bed
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Nausea, Pain, Tenderness, Vaccination site swelling
Clinical narrative: Achy; nauseous; pretty itchy; the injection site is swollen; warm; tender to touch; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warm), TENDERNESS (tender to touch), PAIN (Achy), INJECTION SITE PRURITUS (pretty itchy) and VACCINATION SITE SWELLING (the injection site is swollen) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced VACCINATION SITE WARMTH (warm), TENDERNESS (tender to touch), INJECTION SITE PRURITUS (pretty itchy) and VACCINATION SITE SWELLING (the injection site is swollen). On 06-Feb-2021, the patient experienced PAIN (Achy) and NAUSEA (nauseous). At the time of the report, VACCINATION SITE WARMTH (warm), TENDERNESS (tender to touch) and INJECTION SITE PRURITUS (pretty itchy) outcome was unknown and PAIN (Achy), VACCINATION SITE SWELLING (the injection site is swollen) and NAUSEA (nauseous) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant medication and treatment provided
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: Achy; nauseous; pretty itchy; the injection site is swollen; warm; tender to touch; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warm), TENDERNESS (tender to touch), PAIN (Achy), INJECTION SITE PRURITUS (pretty itchy) and VACCINATION SITE SWELLING (the injection site is swollen) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced VACCINATION SITE WARMTH (warm), TENDERNESS (tender to touch), INJECTION SITE PRURITUS (pretty itchy) and VACCINATION SITE SWELLING (the injection site is swollen). On 06-Feb-2021, the patient experienced PAIN (Achy) and NAUSEA (nauseous). At the time of the report, VACCINATION SITE WARMTH (warm), TENDERNESS (tender to touch) and INJECTION SITE PRURITUS (pretty itchy) outcome was unknown and PAIN (Achy), VACCINATION SITE SWELLING (the injection site is swollen) and NAUSEA (nauseous) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant medication and treatment provided
Sex: M
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pain, Pyrexia, Vaccination site pain
Clinical narrative: Body ache; pyrexia; chills; vaccination site pain; myalgia; This spontaneous case was reported by a nurse and describes the occurrence of PAIN (Body ache), PYREXIA (pyrexia), CHILLS (chills), VACCINATION SITE PAIN (vaccination site pain) and MYALGIA (myalgia) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history was reported.).    On 20-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced PAIN (Body ache), PYREXIA (pyrexia), CHILLS (chills), VACCINATION SITE PAIN (vaccination site pain) and MYALGIA (myalgia). At the time of the report, PAIN (Body ache), PYREXIA (pyrexia), CHILLS (chills), VACCINATION SITE PAIN (vaccination site pain) and MYALGIA (myalgia) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Tremor
Clinical narrative: shakes; Headache; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (shakes) and HEADACHE (Headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Viral infection.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, the patient experienced TREMOR (shakes) and HEADACHE (Headache). On 24-Feb-2021, HEADACHE (Headache) had resolved. At the time of the report, TREMOR (shakes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Positive COVID-19 TesT; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Positive COVID-19 TesT) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history provided). Concomitant products included METFORMIN, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), FINASTERIDE and LOSARTAN for an unknown indication.    On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced COVID-19 (Positive COVID-19 TesT). At the time of the report, COVID-19 (Positive COVID-19 TesT) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Feb-2021, SARS-CoV-2 test positive: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: This is a case of a 74 year old male who tested positive for COVID 19 and without any other symptoms after receiving the first dose of Moderna Vaccine. Based on the information available the event is considered unlikely related to the vaccine. Further information has been requested.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: itchy redness in the area of the injection; itchy redness in the area of the injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (itchy redness in the area of the injection) and VACCINATION SITE PRURITUS (itchy redness in the area of the injection) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history provided).    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (itchy redness in the area of the injection) and VACCINATION SITE PRURITUS (itchy redness in the area of the injection). At the time of the report, VACCINATION SITE ERYTHEMA (itchy redness in the area of the injection) and VACCINATION SITE PRURITUS (itchy redness in the area of the injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant medication and treatment provided   This case was linked to MOD-2021-022839 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: had a rash about a week after vaccination; This spontaneous case was reported by a consumer and describes the occurrence of RASH (had a rash about a week after vaccination) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (had a rash about a week after vaccination). At the time of the report, RASH (had a rash about a week after vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter stated that she knew a few people (her cousin and her neighbor) who also experienced an adverse reaction after receiving the Moderna COVID19 Vaccine. She stated that both patients had a rash about a week after vaccination.  Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-086393 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: Followup received on 21-APR-2021 and contains e-mail details.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-086393:Crosslink
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Myalgia, Renal pain
Clinical narrative: kidney pain; body ache; This spontaneous case was reported by a physician and describes the occurrence of RENAL PAIN (kidney pain) and MYALGIA (body ache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced RENAL PAIN (kidney pain) and MYALGIA (body ache). At the time of the report, RENAL PAIN (kidney pain) and MYALGIA (body ache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Jan-2021, Body temperature: 100.4 100.4.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided.  Treatment information was not provided.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Gait disturbance, Headache, Heart rate increased
Clinical narrative: shortness of breath; hard to walk up stairs; fast heartbeat; headache; exhaustion; muscle pain in back; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath), GAIT DISTURBANCE (hard to walk up stairs), HEART RATE INCREASED (fast heartbeat), HEADACHE (headache) and FATIGUE (exhaustion) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M2OA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced DYSPNOEA (shortness of breath), GAIT DISTURBANCE (hard to walk up stairs), HEART RATE INCREASED (fast heartbeat), HEADACHE (headache), FATIGUE (exhaustion) and MYALGIA (muscle pain in back). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DYSPNOEA (shortness of breath), GAIT DISTURBANCE (hard to walk up stairs), HEART RATE INCREASED (fast heartbeat), HEADACHE (headache), FATIGUE (exhaustion) and MYALGIA (muscle pain in back) outcome was unknown.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: shortness of breath; hard to walk up stairs; fast heartbeat; headache; exhaustion; muscle pain in back; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath), GAIT DISTURBANCE (hard to walk up stairs), HEART RATE INCREASED (fast heartbeat), HEADACHE (headache) and FATIGUE (exhaustion) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M2OA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced DYSPNOEA (shortness of breath), GAIT DISTURBANCE (hard to walk up stairs), HEART RATE INCREASED (fast heartbeat), HEADACHE (headache), FATIGUE (exhaustion) and MYALGIA (muscle pain in back). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DYSPNOEA (shortness of breath), GAIT DISTURBANCE (hard to walk up stairs), HEART RATE INCREASED (fast heartbeat), HEADACHE (headache), FATIGUE (exhaustion) and MYALGIA (muscle pain in back) outcome was unknown.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Headache, Pyrexia
Clinical narrative: Headache; Fever; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), PYREXIA (Fever) and FATIGUE (Fatigue) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache), PYREXIA (Fever) and FATIGUE (Fatigue). At the time of the report, HEADACHE (Headache), PYREXIA (Fever) and FATIGUE (Fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: increased (High) not higher than 100F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter Treatment information was not provided by the reporter   Most recent FOLLOW-UP information incorporated above includes: On 08-Feb-2021: Updated Reporter's address, patient demographics (age at the time of event, date of birth) and suspect drug batch no. and anatomical location
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Back pain, Breast discomfort, Breast tenderness
Clinical narrative: Flu symptoms 2 weeks after vaccination for 3 days; bed rested; right breast was tender; right breast was hot to touch; joint hurt; body ache in other area; severe cold sore; something behind her eye and it was sensitive to light and sore while blinking; something behind her eye and it was sensitive to light and sore while blinking; fatigue; Lower back pain; sore arm; redness; Swelling; lethargic; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), ERYTHEMA (redness), SWELLING (Swelling), LETHARGY (lethargic) and PHOTOPHOBIA (something behind her eye and it was sensitive to light and sore while blinking) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included IBUPROFEN, LEVOTHYROXINE SODIUM (SYNTHROID), CLARITHROMYCIN (MACROBID [CLARITHROMYCIN]) and ESTROGEN NOS for an unknown indication.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm), ERYTHEMA (redness), SWELLING (Swelling) and LETHARGY (lethargic). On 29-Jan-2021, the patient experienced PHOTOPHOBIA (something behind her eye and it was sensitive to light and sore while blinking), EYE PAIN (something behind her eye and it was sensitive to light and sore while blinking), FATIGUE (fatigue) and BACK PAIN (Lower back pain). On 30-Jan-2021, the patient experienced PAIN (body ache in other area) and ORAL HERPES (severe cold sore). On 31-Jan-2021, the patient experienced ARTHRALGIA (joint hurt). On 02-Feb-2021, the patient experienced BREAST TENDERNESS (right breast was tender) and BREAST DISCOMFORT (right breast was hot to touch). On 03-Feb-2021, the patient experienced ASTHENIA (bed rested). On an unknown date, the patient experienced INFLUENZA (Flu symptoms 2 weeks after vaccination for 3 days). On 18-Jan-2021, PAIN IN EXTREMITY (sore arm), ERYTHEMA (redness), SWELLING (Swelling) and LETHARGY (lethargic) had resolved. At the time of the report, PHOTOPHOBIA (something behind her eye and it was sensitive to light and sore while blinking), EYE PAIN (something behind her eye and it was sensitive to light and sore while blinking), FATIGUE (fatigue), BACK PAIN (Lower back pain), PAIN (body ache in other area), ORAL HERPES (severe cold sore), ARTHRALGIA (joint hurt), BREAST TENDERNESS (right breast was tender), BREAST DISCOMFORT (right breast was hot to touch), ASTHENIA (bed rested) and INFLUENZA (Flu symptoms 2 weeks after vaccination for 3 days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Eye pain, Fatigue, Influenza, Lethargy
Clinical narrative: Flu symptoms 2 weeks after vaccination for 3 days; bed rested; right breast was tender; right breast was hot to touch; joint hurt; body ache in other area; severe cold sore; something behind her eye and it was sensitive to light and sore while blinking; something behind her eye and it was sensitive to light and sore while blinking; fatigue; Lower back pain; sore arm; redness; Swelling; lethargic; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), ERYTHEMA (redness), SWELLING (Swelling), LETHARGY (lethargic) and PHOTOPHOBIA (something behind her eye and it was sensitive to light and sore while blinking) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included IBUPROFEN, LEVOTHYROXINE SODIUM (SYNTHROID), CLARITHROMYCIN (MACROBID [CLARITHROMYCIN]) and ESTROGEN NOS for an unknown indication.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm), ERYTHEMA (redness), SWELLING (Swelling) and LETHARGY (lethargic). On 29-Jan-2021, the patient experienced PHOTOPHOBIA (something behind her eye and it was sensitive to light and sore while blinking), EYE PAIN (something behind her eye and it was sensitive to light and sore while blinking), FATIGUE (fatigue) and BACK PAIN (Lower back pain). On 30-Jan-2021, the patient experienced PAIN (body ache in other area) and ORAL HERPES (severe cold sore). On 31-Jan-2021, the patient experienced ARTHRALGIA (joint hurt). On 02-Feb-2021, the patient experienced BREAST TENDERNESS (right breast was tender) and BREAST DISCOMFORT (right breast was hot to touch). On 03-Feb-2021, the patient experienced ASTHENIA (bed rested). On an unknown date, the patient experienced INFLUENZA (Flu symptoms 2 weeks after vaccination for 3 days). On 18-Jan-2021, PAIN IN EXTREMITY (sore arm), ERYTHEMA (redness), SWELLING (Swelling) and LETHARGY (lethargic) had resolved. At the time of the report, PHOTOPHOBIA (something behind her eye and it was sensitive to light and sore while blinking), EYE PAIN (something behind her eye and it was sensitive to light and sore while blinking), FATIGUE (fatigue), BACK PAIN (Lower back pain), PAIN (body ache in other area), ORAL HERPES (severe cold sore), ARTHRALGIA (joint hurt), BREAST TENDERNESS (right breast was tender), BREAST DISCOMFORT (right breast was hot to touch), ASTHENIA (bed rested) and INFLUENZA (Flu symptoms 2 weeks after vaccination for 3 days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Oral herpes, Pain, Pain in extremity, Photophobia, Swelling
Clinical narrative: Flu symptoms 2 weeks after vaccination for 3 days; bed rested; right breast was tender; right breast was hot to touch; joint hurt; body ache in other area; severe cold sore; something behind her eye and it was sensitive to light and sore while blinking; something behind her eye and it was sensitive to light and sore while blinking; fatigue; Lower back pain; sore arm; redness; Swelling; lethargic; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), ERYTHEMA (redness), SWELLING (Swelling), LETHARGY (lethargic) and PHOTOPHOBIA (something behind her eye and it was sensitive to light and sore while blinking) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included IBUPROFEN, LEVOTHYROXINE SODIUM (SYNTHROID), CLARITHROMYCIN (MACROBID [CLARITHROMYCIN]) and ESTROGEN NOS for an unknown indication.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm), ERYTHEMA (redness), SWELLING (Swelling) and LETHARGY (lethargic). On 29-Jan-2021, the patient experienced PHOTOPHOBIA (something behind her eye and it was sensitive to light and sore while blinking), EYE PAIN (something behind her eye and it was sensitive to light and sore while blinking), FATIGUE (fatigue) and BACK PAIN (Lower back pain). On 30-Jan-2021, the patient experienced PAIN (body ache in other area) and ORAL HERPES (severe cold sore). On 31-Jan-2021, the patient experienced ARTHRALGIA (joint hurt). On 02-Feb-2021, the patient experienced BREAST TENDERNESS (right breast was tender) and BREAST DISCOMFORT (right breast was hot to touch). On 03-Feb-2021, the patient experienced ASTHENIA (bed rested). On an unknown date, the patient experienced INFLUENZA (Flu symptoms 2 weeks after vaccination for 3 days). On 18-Jan-2021, PAIN IN EXTREMITY (sore arm), ERYTHEMA (redness), SWELLING (Swelling) and LETHARGY (lethargic) had resolved. At the time of the report, PHOTOPHOBIA (something behind her eye and it was sensitive to light and sore while blinking), EYE PAIN (something behind her eye and it was sensitive to light and sore while blinking), FATIGUE (fatigue), BACK PAIN (Lower back pain), PAIN (body ache in other area), ORAL HERPES (severe cold sore), ARTHRALGIA (joint hurt), BREAST TENDERNESS (right breast was tender), BREAST DISCOMFORT (right breast was hot to touch), ASTHENIA (bed rested) and INFLUENZA (Flu symptoms 2 weeks after vaccination for 3 days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Pyrexia
Clinical narrative: felt a little bit uncomfortable; Fever of 103/temperature of 103 F; This spontaneous case was reported by a patient and describes the occurrence of DISCOMFORT (felt a little bit uncomfortable) and PYREXIA (Fever of 103/temperature of 103 F) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history provided by reporter.  Concomitant products included DIAZEPAM, GABAPENTIN, LEVOTHYROXINE, GLICLAZIDE (MICROZIDE [GLICLAZIDE]), MORPHINE SULFATE (MS CONTIN) and ATORVASTATIN for an unknown indication.   On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DISCOMFORT (felt a little bit uncomfortable) and PYREXIA (Fever of 103/temperature of 103 F). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. At the time of the report, DISCOMFORT (felt a little bit uncomfortable) and PYREXIA (Fever of 103/temperature of 103 F) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pyrexia: 103 (High) 103.         Concomitant medication also included Promapar twice a day.   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Event discomfort, concomitant medications, start date and anatomical location for the suspect vaccination, treatment medication for the event fever all were added.
Sex: U
Vaccine: COVID19
Symptoms: Injection site pruritus, Malaise, Myalgia, Pain in extremity, Vaccination site inflammation
Clinical narrative: Mild malaise; Injection site very itchy; Arm inflammation; Arm swelling; Sore arm; Muscle ache/  Back muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Mild malaise), VACCINATION SITE INFLAMMATION (Arm inflammation), PAIN IN EXTREMITY (Sore arm), VACCINATION SITE SWELLING (Arm swelling) and INJECTION SITE PRURITUS (Injection site very itchy) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced VACCINATION SITE INFLAMMATION (Arm inflammation) and VACCINATION SITE SWELLING (Arm swelling). On an unknown date, the patient experienced MALAISE (Mild malaise), PAIN IN EXTREMITY (Sore arm), INJECTION SITE PRURITUS (Injection site very itchy) and MYALGIA (Muscle ache/  Back muscle aches). The patient was treated with HYDROCORTISONE (topical) for Adverse event, at a dose of 10% cream. At the time of the report, MALAISE (Mild malaise), VACCINATION SITE INFLAMMATION (Arm inflammation), PAIN IN EXTREMITY (Sore arm), VACCINATION SITE SWELLING (Arm swelling), INJECTION SITE PRURITUS (Injection site very itchy) and MYALGIA (Muscle ache/  Back muscle aches) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant medication not provided.  The patient reported the injection site swelling and inflammation resolved about 2 and a half weeks after the first shot.   Most recent FOLLOW-UP information incorporated above includes: On 05-Feb-2021: Follow-up information received updated event outcome. On 28-Jun-2021: Follow-up received updated event and suspect dosage details.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Mild malaise; Injection site very itchy; Arm inflammation; Arm swelling; Sore arm; Muscle ache/  Back muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Mild malaise), VACCINATION SITE INFLAMMATION (Arm inflammation), PAIN IN EXTREMITY (Sore arm), VACCINATION SITE SWELLING (Arm swelling) and INJECTION SITE PRURITUS (Injection site very itchy) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced VACCINATION SITE INFLAMMATION (Arm inflammation) and VACCINATION SITE SWELLING (Arm swelling). On an unknown date, the patient experienced MALAISE (Mild malaise), PAIN IN EXTREMITY (Sore arm), INJECTION SITE PRURITUS (Injection site very itchy) and MYALGIA (Muscle ache/  Back muscle aches). The patient was treated with HYDROCORTISONE (topical) for Adverse event, at a dose of 10% cream. At the time of the report, MALAISE (Mild malaise), VACCINATION SITE INFLAMMATION (Arm inflammation), PAIN IN EXTREMITY (Sore arm), VACCINATION SITE SWELLING (Arm swelling), INJECTION SITE PRURITUS (Injection site very itchy) and MYALGIA (Muscle ache/  Back muscle aches) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant medication not provided.  The patient reported the injection site swelling and inflammation resolved about 2 and a half weeks after the first shot.   Most recent FOLLOW-UP information incorporated above includes: On 05-Feb-2021: Follow-up information received updated event outcome. On 28-Jun-2021: Follow-up received updated event and suspect dosage details.
Age: 94.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Somnolence
Clinical narrative: Body aches; Long sleep; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches) and SOMNOLENCE (Long sleep) in a 94-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 026L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history provided).   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosae. On 05-Feb-2021, the patient experienced PAIN (Body aches) and SOMNOLENCE (Long sleep). At the time of the report, PAIN (Body aches) and SOMNOLENCE (Long sleep) outcome was unknown.            no treatment provided no concomitant medication given   Most recent FOLLOW-UP information incorporated above includes: On 05-Feb-2021: No specific follow-up information recorded.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Peripheral swelling, Pruritus, Rash macular, Vaccination site warmth
Clinical narrative: Large pink spot 4 inches down on her arm; Arm swollen and Arm looked like a big bicep; Arm itching; Arm warm to the touch; Light muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (Large pink spot 4 inches down on her arm), PERIPHERAL SWELLING (Arm swollen and Arm looked like a big bicep), PRURITUS (Arm itching), VACCINATION SITE WARMTH (Arm warm to the touch) and MYALGIA (Light muscle pain) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included ZINC, CALCIUM, MAGNESIUM and ELWENDIA PERSICA OIL (BLACK SEED [ELWENDIA PERSICA OIL]) for an unknown indication.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced RASH MACULAR (Large pink spot 4 inches down on her arm), PERIPHERAL SWELLING (Arm swollen and Arm looked like a big bicep), PRURITUS (Arm itching), VACCINATION SITE WARMTH (Arm warm to the touch) and MYALGIA (Light muscle pain). At the time of the report, RASH MACULAR (Large pink spot 4 inches down on her arm), PERIPHERAL SWELLING (Arm swollen and Arm looked like a big bicep), PRURITUS (Arm itching), VACCINATION SITE WARMTH (Arm warm to the touch) and MYALGIA (Light muscle pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided. Relevant concomitant medications also included blood pressure medications, thyroid medications and vitamins.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Dizziness, Electrocardiogram abnormal, Hyperhidrosis
Clinical narrative: diaphoresis, chest pain, lightheadedness
Age: 62.0
Sex: M
Vaccine: VARZOS
Symptoms: Asthenia, Headache, Nausea, Pain, Pyrexia
Clinical narrative: -  Symptoms:  bodily aches & pains, headache, feverish, nausea, weakness -  Note: I do not know which Zoster vaccine I received (Shingrix or Zostavax).
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Fatigue, Headache, Hyperhidrosis, Nausea
Clinical narrative: 12 hours after  2nd shot severe chills, shivering fever nausea sweating pain all over body.  next day 8/10 couldn't get out of bed slept all day body pains fatigue  headache.  8/12 nausea and diarrhea . I didn't know about this site and with the first shot I lost a day of work due to headache and body pain too/
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain, Pyrexia
Clinical narrative: 12 hours after  2nd shot severe chills, shivering fever nausea sweating pain all over body.  next day 8/10 couldn't get out of bed slept all day body pains fatigue  headache.  8/12 nausea and diarrhea . I didn't know about this site and with the first shot I lost a day of work due to headache and body pain too/